The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Globe Investor

News Sources

Take control of your investments with the latest investing news and analysis

Press release from PR Newswire

BD Acquires KIESTRA Lab Automation BV

Monday, February 13, 2012

BD Acquires KIESTRA Lab Automation BV08:00 EST Monday, February 13, 2012Provides Automation Platform to Offer Integrated Microbiology Lab SolutionsFRANKLIN LAKES, N.J., Feb. 13, 2012 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that it has acquired KIESTRA Lab Automation BV, a Netherlands-based company that designs, develops, manufactures, markets and sells innovative lab automation solutions for the microbiology lab. The financial terms of the acquisition were not disclosed. The transaction is expected to be slightly dilutive; however, BD reaffirms its previous guidance that reported diluted earnings per share from continuing operations for fiscal year 2012 are expected to be in the range of $5.60 to $5.70.For further information, read more on BD's website.About BDBD is a leading global medical technology company that develops, manufactures and sells medical devices, instrument systems and reagents. The Company is dedicated to improving people's health throughout the world.  BD is focused on improving drug delivery, enhancing the quality and speed of diagnosing infectious diseases and cancers, and advancing research, discovery and production of new drugs and vaccines. BD's capabilities are instrumental in combating many of the world's most pressing diseases. Founded in 1897 and headquartered in Franklin Lakes, New Jersey, BD employs approximately 29,000 associates in more than 50 countries throughout the world. The Company serves healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public. For more information, please visit www.bd.com.Contacts:Colleen T. White, Corporate Communications ? 201-847-5369Colleen_white@bd.comMonique N. Dolecki, Investor Relations ? 201-847-5453Monique_dolecki@bd.comSOURCE BD (Becton, Dickinson and Company)